ALPS Advisors’s Pacira BioSciences PCRX Stock Holding History

ALPS Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-72,484	Closed	-$3.56M	–	923
2018 Q3	$3.56M	Buy	72,484 +13,370	+23%	+$578K	0.02%	188
2018 Q2	$1.9M	Buy	59,114 +4,701	+9%	+$162K	0.01%	234
2018 Q1	$1.7M	Buy	54,413 +9,457	+21%	+$337K	0.01%	227
2017 Q4	$2.05M	Buy	44,956 +5,225	+13%	+$207K	0.01%	195
2017 Q3	$1.49M	Buy	39,731 +3,546	+10%	+$143K	0.01%	207
2017 Q2	$1.73M	Buy	36,185 +4,008	+12%	+$186K	0.01%	191
2017 Q1	$1.47M	Sell	32,177 -3,766	-10%	-$163K	0.01%	189
2016 Q4	$1.16M	Sell	35,943 -11,581	-24%	-$386K	0.01%	208
2016 Q3	$1.63M	Sell	47,524 -4,688	-9%	-$184K	0.01%	198
2016 Q2	$1.76M	Buy	52,212 +10,542	+25%	+$518K	0.02%	178
2016 Q1	$2.21M	Sell	41,670 -6,752	-14%	-$395K	0.02%	148
2015 Q4	$3.72M	Sell	48,422 -8,938	-16%	-$506K	0.04%	135
2015 Q3	$23.6K	Buy	57,360 +21,190	+59%	+$1.3M	0.02%	156
2015 Q2	$2.56M	Buy	36,170 +18,135	+101%	+$1.43M	0.02%	150
2015 Q1	$1.6M	Buy	+18,035	New	+$1.83M	0.01%	161

Other funds holding PCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return